National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

ferumoxsil oral suspension
An orally administered aqueous suspension of silicone-coated, superparamagnetic iron oxide used as a magnetic resonance imaging (MRI) contrast agent. After oral administration, ferumoxsil fills the stomach and intestines. Upon exposure to the strong external magnetic field during MRI, ferumoxsil exhibits strong T1 relaxation properties and a strongly varying local magnetic field; T2 relaxation is enhanced, thereby darkening the contrast agent-containing portion of the gastrointestinal tract. Delineation of the bowel is thus enhanced, distinguishing bowel from organs and tissues adjacent to the upper regions of the gastrointestinal tract. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:GastroMARK
Lumirem



Previous:fentanyl sublingual spray, fermented soybean protein beverage, fermented wheat germ extract, Ferrlecit, ferrous sulfate
Next:ferumoxtran-10, ferumoxytol, FGFR1 receptor antagonist FP-1039, fibrin sealant, Fidelin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov